Cough Assist Devices Market Set to Double to USD 547.99 Million by 2034 Driven by Technological Advances and Rising Neuromuscular Disorders

The global cough assist devices market size is calculated at USD 295.91 million in 2025 and is expected to reach around USD 547.99 million by 2034, growing at a CAGR of 7.24% for the forecasted period.

Ottawa, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The global cough assist devices market size was valued at USD 275.99 million in 2024 and is predicted to hit around USD 547.99 million by 2034, rising at a 7.24% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.

Ongoing technological breakthroughs and the growing cases of spinal cord injury or neuromuscular disorders are fueling the market expansion.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5459

Key Takeaways

North America was dominant in the market in 2024.
Asia-Pacific is expected to grow rapidly during 2025-2034 in the cough assist devices market.
By product type, the automatic cough assist device segment led the market in 2024 and is expected to sustain its dominance in the coming years.
By choice of delivery, the mouthpiece segment dominated the market in 2024 and is expected to grow at the fastest CAGR in the studied years.
By end-use, the hospitals segment registered dominance in the cough assist devices market in 2024.
By end-use, the home care settings segment is expected to witness rapid expansion during 2025-2034.

What are the Cough Assist Devices?

These devices are also termed as mechanical insufflator-exsufflators (MI-E), which are non-invasive in nature, used to emulate a natural cough to clear mucus and secretions from the airways. In 2025, the cough assist devices market is expanding due to the growing use of these devices in amyotrophic lateral sclerosis (ALS), muscular dystrophy, and spinal cord injuries, impairing the natural ability to cough.

Currently, the market is emphasizing improvements in patient comfort and clinical outcomes through features, especially adjustable pressure settings, multiple interface options (masks, mouthpieces, tracheostomy adapters), optimized digital controls, and integration with therapy management systems for more customized and efficient care.

Report Scope:

Metric	Details
Market Size in 2024	USD 275.99 Million
Projected Market Size in 2034	USD 547.99 Million
CAGR (2025 - 2034)	7.24	%
Leading Region	North America
Market Segmentation	By Product Type, By Choice of Delivery, By End-Use and By Region
Top Key Players	Dima Italia Srl, Genotronics, Hill-Rom Holdings, Inc., Intersurgical, Inc., McKesson Corporation, Oxycare Medical Group, Percussionaire Corp., Philips Respironics, US Med-Equip, Ventec Life Systems, Wave Healthcare

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What are the Key Drivers in the Cough Assist Devices Market?

Around the globe, the growing population is possessing a huge burden of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and severe asthma, as well as other conditions, like muscular dystrophy, myasthenia gravis, amyotrophic lateral sclerosis (ALS), and spinal cord injuries are highly demanding for cough assist devices. Alongside, the digital world is focusing on the preference and requirement for healthcare services and devices in at-home settings, resulting in greater demand for portable and user-friendly cough assist devices.

What are the Major Drifts in the Cough Assist Devices Market?

Nowadays, the digital solution development is transforming diverse devices used in respiratory conditions, with the emergence of AI and other technologies.

In August 2025, Apreo Health, a clinical-stage medical device company, raised $130M to advance the BREATHE Airway Scaffold device.
In August 2025, Apreo Health raised $130 million to fund a pivotal trial and early commercialization of a device for treating severe emphysema.
In August 2024, Salcit Technologies, an India-based respiratory healthcare company, partnered with the Google Research team to leverage how Google’s Health Acoustic Representations (HeAR) can foster the capabilities of Salcit’s bioacoustic AI technology, Swaasa.

What is the Emerging Challenge in the Market?

These sophisticated devices are expensive, which creates a barrier to their availability in less affluent areas. The global cough assist devices market is further facing limitations in the higher need for professional guidance from respiratory therapists to operate the device's settings and align their breathing patterns for efficient application and comfort.

Regional Analysis

How did North America Dominate the Market in 2024?

North America’s cough assist devices market captured a major share in 2024. North America’s rising geriatric population is highly prone to various respiratory disorders, and neuromuscular issues are impacting the broader range of demand for these advanced devices. Additionally, this region is encouraging the revolution of more compact, lightweight, and user-friendly devices that are feasible to use in home care settings.

For instance,

In May 2025, ABM Respiratory Care, an innovator in respiratory therapy solutions, collaborated with Delve Health, a trailblazer in decentralized clinical trial technology, to examine the impact of its BiWaze Clear System in patients living with bronchiectasis.

Why did the Asia Pacific Grow Notably in the Market in 2024?

During 2025-2034, the Asia Pacific is predicted to register rapid growth in the cough assist devices market. Asia Pacific’s expanding urbanization and pollution levels are boosting the generation of instances of respiratory concerns. This further fueled demand for supportive devices, including cough assist devices. Whereas, ASAP’s governments are emphasizing the enhancement of healthcare access and infrastructure, which helps in the adoption of advanced respiratory devices and accelerates the availability of these products.

For instance,

In October 2024, AGAPE ATP Corporation (ATPC) partnered with FORMEDIC Technologies Sdn. Bhd. to launch LEGA, an electronic chest percussion device evolved for respiratory care.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Segmental Insights

By product type analysis

What Made the Automatic Cough Assist Device Segment Dominant in the Market in 2024?

The automatic cough assist device segment held the largest revenue share of the cough assist devices market. The segment is driven by the ongoing decentralization of healthcare and the raised adoption of homecare models are developing a demand for portable, lightweight, and easy-to-operate cough assist devices. Advanced devices, like the Siva Health device is a medical-grade wearable systems which is applying AI for consistent, long-term cough monitoring in clinical settings, offering objective data for trials and patient management. The emergence of Internet of Medical Things (IoMT) technology is allowing seamless, remote data sharing among patients and caregivers, which ultimately enhances care quality and workflow efficiency.

By choice of delivery analysis

How did the Mouthpiece Segment Lead the Market in 2024?

In 2024, the mouthpiece segment registered dominance and will expand rapidly in the cough assist devices market. Nowadays, the worldwide patients and caregivers are looking for convenient and comfortable, non-invasive treatment choices for chronic concerns, making devices with a mouthpiece or mask delivery widely adaptable. Alongside, transforming hardware, including specialized mouthpiece interfaces and ventilator software, is used to omit disconnection alarms and escalate application in long-term ventilation is propelling the overall market expansion. Although mouthpiece ventilation facilitates higher practicality and possibly reduces morbidities than tracheostomy ventilation.

By end-use analysis

How did the Hospitals Segment Dominate the Market in 2024?

The hospitals segment captured the dominant share of the cough assist devices market in 2024. The well-developed hospitals comprise the resources and specialized professionals that are essential to perform and maintain advanced equipment, particularly cough assist machines, further enabling them to deliver optimal patient care. Besides this, an emerging trend of the integrated non-invasive ventilation support, likewise cough assist devices, is being adopted into respiratory therapy programs within hospitals, eventually in pediatric neurology and geriatric care units.

Whereas the home care settings segment is anticipated to expand at a rapid CAGR. A rise in demand for portable, affordable, smaller, lightweight, and battery-powered devices is boosting the transformations in home care settings. However, the globe is pushing advances in AI integration and digital connectivity, which are providing features, such as Cough-Trak for user-initiated therapy, remote monitoring capabilities, and automated AI-powered cough tracking. This further expands the development of user-friendly, tailored, and efficient approaches for patients used in muscular dystrophy and neuromuscular diseases.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

What are the Recent Developments in the Cough Assist Devices Market?

In January 2025, ActiGraph, the global player in wearable digital health technology for clinical research and drug development, and Hyfe Inc., unveiled their new digital health solution for the detection of coughs employing the ActiGraph LEAP wearable.
In December 2024, ZQuiet launched the ZQuiet Advance, an anti-snoring mouthpiece featuring a customizable fit with moldable trays, adjustable settings with four levels of jaw advancement, and a slim, lightweight design.
In December 2024, electronRx, a leading digital medicine and biomarker company, launched purpleDx, a cardiopulmonary assessment app to build medical device standards, at CES 2025 from 7-10 Jan in Las Vegas, USA.
In June 2024, React Health launched IntelliPAP, an auto-adjusting PEEP option for the V*Home, V+Pro, V+C, and VC+Pro ventilators.

Cough Assist Devices Market Key Players List

Dima Italia Srl
Genotronics
Hill-Rom Holdings, Inc.
Intersurgical, Inc.
McKesson Corporation
Oxycare Medical Group
Percussionaire Corp.
Philips Respironics
US Med-Equip
Ventec Life Systems
Wave Healthcare

Browse More Insights of Towards Healthcare:

The global anesthesia devices market is valued at USD 17.52 billion in 2024, expected to grow to USD 19.04 billion in 2025, and projected to reach around USD 40.16 billion by 2034, expanding at a CAGR of 8.65% between 2025 and 2034.
The global intranasal drug delivery devices market is estimated at USD 1.74 billion in 2024, projected to increase to USD 1.91 billion in 2025, and anticipated to achieve USD 4.54 billion by 2034, growing at a CAGR of 10.04% over the forecast period.
The global pharmacy automation devices market stands at USD 7.6 billion in 2024, rising to USD 8.37 billion in 2025, and forecasted to reach USD 19.9 billion by 2034, advancing at a CAGR of 10.1% from 2025 to 2034.
The global continuous blood pressure monitoring devices market is witnessing strong growth momentum and is expected to generate significant revenues, potentially reaching the hundreds of millions by 2034.
The global smart medical devices market is valued at USD 24.82 billion in 2024, increasing to USD 26.62 billion in 2025, and set to reach USD 49 billion by 2034, growing at a CAGR of 7.26% between 2025 and 2034.
The global insulin drugs and delivery devices market totals USD 23.75 billion in 2024, rising to USD 25.58 billion in 2025, and projected to attain USD 49.18 billion by 2034, registering a CAGR of 7.65% during 2025–2034.
The global digital health monitoring devices market reached USD 5.23 billion in 2024 and is expected to expand to USD 6.22 billion in 2025. By 2034, it is projected to reach USD 29.71 billion, growing at a robust CAGR of 18.9%.
The orthopedic 3D printing devices market is valued at USD 2.48 billion in 2024, rising to USD 2.75 billion in 2025, and forecasted to reach USD 6.87 billion by 2034, progressing at a CAGR of 11.24% during the forecast period.
The global cell and gene therapy drug delivery devices market is on a rapid growth path, with revenue potential expected to climb into the hundreds of millions between 2025 and 2034.
The global point-of-care molecular diagnostics market is valued at USD 4.05 billion in 2024, increasing to USD 4.48 billion in 2025, and anticipated to reach USD 11.03 billion by 2034, advancing at a CAGR of 10.45% over the forecast years.

Segments Covered in The Report

By Product Type

Automatic Cough Assist Device
Manual Cough Assist Device

By Choice of Delivery

Mouthpiece
Face Mask
Adapter

By End-Use

Home Care Settings
Hospitals
Others

By Region

North America
- U.S.
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Latin America
- Brazil
- Mexico
- Argentina
Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5459

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.